215 related articles for article (PubMed ID: 25170571)
21. Minimum infusion rate and adrenocortical function after continuous infusion of the novel etomidate analog ET-26-HCl in rats.
Jiang J; Wang B; Zhu Z; Yang J; Liu J; Zhang W
PeerJ; 2017; 5():e3693. PubMed ID: 28890850
[TBL] [Abstract][Full Text] [Related]
22. Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function.
Cotten JF; Forman SA; Laha JK; Cuny GD; Husain SS; Miller KW; Nguyen HH; Kelly EW; Stewart D; Liu A; Raines DE
Anesthesiology; 2010 Mar; 112(3):637-44. PubMed ID: 20179500
[TBL] [Abstract][Full Text] [Related]
23. Etomidate--a review of robust evidence for its use in various clinical scenarios.
Erdoes G; Basciani RM; Eberle B
Acta Anaesthesiol Scand; 2014 Apr; 58(4):380-9. PubMed ID: 24588359
[TBL] [Abstract][Full Text] [Related]
24. [Quality of induction and adrenocortical function. A clinical comparison of Etomidate-Lipuro and Hypnomidate].
Vanacker B; Wiebalck A; Van Aken H; Sermeus L; Bouillon R; Amery A
Anaesthesist; 1993 Feb; 42(2):81-9. PubMed ID: 8470789
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic evaluation study of etomidate: a randomized, open-label, 2-period crossover study in healthy Chinese subjects.
Ding Y; Chu NN; Wang R; Qin W; Shi YF; Qian ZZ; Liu B; He Q
Sci Rep; 2024 Mar; 14(1):7071. PubMed ID: 38528026
[TBL] [Abstract][Full Text] [Related]
26. Metabolite-inactive etomidate analogues alleviating suppression on adrenal function in Beagle dogs.
Yang J; Kang Y; Wang B; Yang L; Liu J; Zhang W
Eur J Pharm Sci; 2017 Mar; 99():343-349. PubMed ID: 28057551
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.
Pejo E; Feng Y; Chao W; Cotten JF; Le Ge R; Raines DE
Crit Care Med; 2012 Jan; 40(1):187-92. PubMed ID: 21926608
[TBL] [Abstract][Full Text] [Related]
28. Behavioral and steroidogenic pharmacology of phenyl ring substituted etomidate analogs in rats.
McGrath M; Hofmann A; Raines DE
BMC Pharmacol Toxicol; 2019 Aug; 20(1):48. PubMed ID: 31383012
[TBL] [Abstract][Full Text] [Related]
29. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy.
Avramov MN; Husain MM; White PF
Anesth Analg; 1995 Sep; 81(3):596-602. PubMed ID: 7653829
[TBL] [Abstract][Full Text] [Related]
30. The effect of repeated etomidate anesthesia on adrenocortical function during a course of electroconvulsive therapy.
Wang N; Wang XH; Lu J; Zhang JY
J ECT; 2011 Dec; 27(4):281-5. PubMed ID: 22080238
[TBL] [Abstract][Full Text] [Related]
31. The preclinical pharmacological study of a novel intravenous anesthetic, ET-26 hydrochloride, in aged rats.
Chang P; Su Y; Gong D; Kang Y; Liu J; Zhang Y; Zhang WS
PeerJ; 2022; 10():e13995. PubMed ID: 36196398
[TBL] [Abstract][Full Text] [Related]
32. Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of etomidate in the rat.
De Paepe P; Belpaire FM; Van Hoey G; Boon PA; Buylaert WA
J Pharmacol Exp Ther; 1999 Sep; 290(3):1048-53. PubMed ID: 10454477
[TBL] [Abstract][Full Text] [Related]
33. Propofol: a sedative-hypnotic anesthetic agent for use in ambulatory procedures.
Steinbacher DM
Anesth Prog; 2001; 48(2):66-71. PubMed ID: 11515950
[No Abstract] [Full Text] [Related]
34. ET-26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats.
Wang B; Chen S; Yang J; Yang L; Liu J; Zhang W
PLoS One; 2017; 12(8):e0183439. PubMed ID: 28813523
[TBL] [Abstract][Full Text] [Related]
35. The effect of midazolam or lidocaine administration prior to etomidate induction of anesthesia on heart rate, arterial pressure, intraocular pressure and serum cortisol concentration in healthy dogs.
Keating SC; Sage AM; Ambrisko TD; Somrak A; Carroll MQ; Oba PM; Martins B; Swanson KS
Vet Anaesth Analg; 2020 Mar; 47(2):160-167. PubMed ID: 31813669
[TBL] [Abstract][Full Text] [Related]
36. Clinical and molecular pharmacology of etomidate.
Forman SA
Anesthesiology; 2011 Mar; 114(3):695-707. PubMed ID: 21263301
[TBL] [Abstract][Full Text] [Related]
37. Toxicologic and Inhibitory Receptor Actions of the Etomidate Analog ABP-700 and Its Metabolite CPM-Acid.
Valk BI; McGrath M; Lehoux D; Zerler B; Marota JJA; Raines DE
Anesthesiology; 2019 Aug; 131(2):287-304. PubMed ID: 31166238
[TBL] [Abstract][Full Text] [Related]
38. Duration of etomidate-induced adrenocortical suppression during surgery in dogs.
Dodam JR; Kruse-Elliott KT; Aucoin DP; Swanson CR
Am J Vet Res; 1990 May; 51(5):786-8. PubMed ID: 2337278
[TBL] [Abstract][Full Text] [Related]
39. AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis.
Egan TD; Obara S; Jenkins TE; Jaw-Tsai SS; Amagasu S; Cook DR; Steffensen SC; Beattie DT
Anesthesiology; 2012 Jun; 116(6):1267-77. PubMed ID: 22531340
[TBL] [Abstract][Full Text] [Related]
40. Hypnoanalgesia with R 8110/fentanyl in the dog: pharmacodynamic and pharmacokinetic interactions.
Monbaliu J; Degryse AD; Ooms LA; Van Dijk P; Lagerweij E; Michiels M; Woestenborghs R; Heykants J
J Vet Pharmacol Ther; 1988 Mar; 11(1):63-70. PubMed ID: 3379665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
